Stephen M Sorensen

Title: The Innovations of Stephen M. Sorensen

Introduction

Stephen M. Sorensen is a notable inventor based in Chester, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of behavioral and psychological symptoms associated with various diseases. With a total of 4 patents to his name, Sorensen's work has the potential to impact many lives.

Latest Patents

Among his latest patents, one focuses on the use of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol or its prodrug in treating behavioral or psychological symptoms associated with Alzheimer's disease, Lewy body dementia, or Parkinson's disease. This invention aims to provide a therapeutic option for patients suffering from these debilitating conditions. Another patent addresses the treatment of substance-induced insomnia, detailing a method of providing symptomatic relief through the administration of R-(+)-α-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol or a pharmaceutically acceptable salt thereof.

Career Highlights

Stephen M. Sorensen is currently associated with Aventis Pharmaceuticals Inc., where he continues to innovate and develop new treatments. His work is characterized by a commitment to improving patient outcomes through scientific research and development.

Collaborations

Throughout his career, Sorensen has collaborated with esteemed colleagues, including Janice M. Hitchcock and Cesare Mondadori. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Stephen M. Sorensen's contributions to the pharmaceutical industry exemplify the impact of dedicated inventors in advancing medical science. His patents reflect a commitment to addressing critical health issues, and his work continues to inspire future innovations.